Protective effect of salvianic acid A on acute liver injury induced by carbon tetrachloride in rats

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 44-47

  Wang, Chao Yun ^a,b   Ma, Fu Lu ^b   Liu, Jun Tian ^a   Tian, Jing Wei ^b   Fu, Feng Hua ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shandong Engineering Research Center for Nature Drug   (China)

Author keywords

Alanine aminotransferase; Antioxidative enzyme; Aspartate aminotransferase; Malondialdehyde; Salvianic acid A; Superoxide anion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OLIVE OIL; SALVIA MILTIORRHIZA EXTRACT; SALVIANIC ACID A; SILYMARIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; MALE; MICROSCOPY; MITOCHONDRIAL MEMBRANE; NONHUMAN; RAT; SPECTROPHOTOMETRY; SUBMITOCHONDRIAL PARTICLE;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CAFFEIC ACIDS; CARBON TETRACHLORIDE; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUTATHIONE PEROXIDASE; LACTATES; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 33846119765     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.44     Document Type: Article

References (23)

1. Bautista A. P., Spitzer J. J., Frontiers Biosci, 15, D589-595 (1999).
2. Videla L. A., Fernandez V., Tapia G., Varela P., Biometals, 16, 103-111 (2003).
3. Lee J. Y., Lee S. H., Kim H. J., Ha J. M., Lee S. H., Lee J. H., Ha B. J., Arch. Pharmacol. Res., 27, 340-345 (2004).
4. Szymonik-Lesiuk S., Czechowska G., Stryjecka-Zimmer M., Slomka M., Madro A., Celinski K., Wielosz M., J. Hepato-biliary-Pancreatic Surg., 10, 309-315 (2003).
5. Fridovich I., Ann. Rev. Pharmacol. Toxicol., 23, 239-257 (1983).
6. Chen W., Dong Y., Wang C., Ting G., Acta Pharmacol. Sin., 14, 277-283 (1979).
7. Han Y. M., Oh H., Na M., Kim B. S., Oh W. K., Kim B. Y., Jeong D. G., Ryu S. E., Sok D.-E., Ahn J. S., Biol. Pharm. Bull., 28, 1795-1797 (2005).
8. Li C., Lou J., Li L., Life Sci., 72, 1563-1571 (2003).
9. Zhao B. L., Jing W., Zhao Y., Hou J. W., Xin W. J., Biochem. Mol. Biol. Int., 38, 1171-1182 (1996).
10. Wang X. J., Wang Z. B., Xu J. X., J. Ethnopharmacol., 97, 441-445 (2005).
11. Wang X. J., Xu J. X., Neurosci. Res., 51, 129-138 (2005).
12. Deng X. L., Chen X. M., Jian F. S., Yao X. C., Chin. J. Pharm., 36, 511-512 (2005).
13. Buege J. A., Aust S., Methods Enzymol., 51, 302-307 (1978).
14. Sohal R. S., Svensson I., Sohal B. H., Brunk U. T., Mech. Aging Dev., 49, 129-135 (1989).
15. Ku H. H., Brunk U. T., Sohal R. S., Free Rad. Biol. Med., 15, 621-627 (1993).
16. Boveris A., Methods Enzymol., 105, 429-435 (1984).
17. Chan P. H., Stroke, 27, 1124-1129 (1996).
18. Takahara S., Hamilton B. M., Nell J. V., Ogura Y., Nishimura E. T., J. Clin. Invest., 29, 610-619 (1960).
19. Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G., Science, 179, 588-590 (1973).
20. Lowry O. H., Rosebrough N. J., Farr A. I., Randall R. I., J. Biol. Chem., 193, 265-275 (1951).
21. Wei Y. H., Proc. Soc. Exp. Biol. Med., 217, 53-63 (1998)
22. Proctor P. H., McGinness J. E., Arch. Dermatol., 122, 507-508 (1986).
23. Halliwell B., Gutteridge J. M., Cross C. E., J. Lab. Clin. Med., 119, 598-620 (1992).